March 2014 tender notification

PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012 and 2013/14 Invitation to Tender, dated 07 November 2013.

Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website.

Where a product does not have a current Pharmacode, suppliers are required to ensure a Pharmacode has been obtained from the Pharmacy Guild of New Zealand before the 12th of the month prior to the date of listing. PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.

2012/13 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2016

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical Name Presentation; Pack size and type Current subsidy and price (brand) New subsidy and price Sole supply brand
(Supplier)
Date of listing/subsidy change for tender winning brand Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) Brand (Supplier) affected by reference pricing and delisting
Pramipexole hydrochloride Tab 0.25 mg;
100 tablets, blister pack
$7.20 per 100 tablets
(Ramipex)

$2.40 per 30 tablets
(Dr Reddy’s)
$7.20 per 100 tablets Ramipex
(Deva Holdings)
1 August 2014 1 October 2014 1 January 2015 Dr Reddy's Pramipexole
(Dr Reddy's)
Pramipexole hydrochloride Tab 1 mg;
100 tablets, blister pack
$24.39 per 100 tablets
(Ramipex)

$7.20 per 30 tablets
(Dr Reddy’s)
$24.39 per 100 tablets Ramipex
(Deva Holdings)
1 August 2014 Not applicable 1 January 2015 Dr Reddy's Pramipexole
(Dr Reddy's)
*Dr Reddy’s brand of pramipexole hydrochloride 0.125 mg and 0.5 mg tablet will also be delisted from Section B of the Pharmaceutical Schedule from 1 January 2015.

Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current subsidy  (and price) New subsidy (and price) Sole supply brand (Supplier) Date of subsidy change Sole Subsidised Supply date
Loperamide hydrochloride Cap 2 mg;
400 capsules, blister pack
$8.95 $7.84 Diamide Relief
(Mylan)
1 May 2014 1 August 2014

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical Name Presentation;
Pack size and type
Current pack price
(brand)
New pack
price
Hospital Supply
Brand (Supplier)
DV
Limit
Date of listing/price change for tender winning brand Hospital Supply Status date (and delisting of other listed brands) Brand (Supplier) to be delisted
Pramipexole hydrochloride Tab 0.25 mg;
100 tablets, blister pack
$7.20 per 100 tablets
(Ramipex)

$2.40 per 30 tablets
(Dr Reddy’s)
$7.20 per 100 tablets Ramipex
(Deva Holdings)
1 % 1 August 2014 1 October 2014 Dr Reddy's Pramipexole
(Dr Reddy's)
Pramipexole hydrochloride Tab 1 mg;
100 tablets, blister pack
$24.39 per 100 tablets
(Ramipex)

$7.20 per 30 tablets
(Dr Reddy’s)
$24.39 per 100 tablets Ramipex
(Deva Holdings)
1 % 1 August 2014 1 October 2014 Dr Reddy's Pramipexole
(Dr Reddy's)
*Dr Reddy’s brand of pramipexole hydrochloride 0.125 mg and 0.5 mg tablet will also be delisted from Part II of Section H of the Pharmaceutical Schedule from 1 October 2014.

Tenders awarded to listed pharmaceuticals where only the current brand is listed.

The decisions were as follows:

Chemical Name Presentation;
Pack size and type
Current pack price New pack price Hospital Supply
Brand (Supplier)
DV
Limit
Date of price change Hospital Supply Status date
Loperamide hydrochloride Cap 2 mg;
400 capsules, blister pack
$8.95 $7.84 Diamide Relief
(Mylan)
1% 1 May 2014 1 July 2014

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical name Presentation; Pack size and type Current subsidy  (and price) New subsidy (and price) Sole supply brand (Supplier) Date of subsidy change Sole Subsidised Supply date
Acetazolamide Tab 250 mg;
100 tablets, bottle
$17.03 $17.03 Diamox
(Aspen)
1 July 2014 1 October 2014
Atropine sulphate Eye drops 1%;
15 ml, dropper bottle
$17.36 $17.36 Atropt
(Aspen)
1 May 2014 1 August 2014
Betaxolol Eye drops 0.25%;
5 ml OP, dropper bottle
$11.80 $11.80 Betoptic S
(Alcon)
1 July 2014 1 October 2014
Betaxolol Eye drops 0.5%;
5 ml OP, dropper bottle
$7.50 $7.50 Betoptic
(Alcon)
1 July 2014 1 October 2014
Cyclopentolate hydrochloride Eye drops 1%;
15 ml OP, dropper bottle
$8.76 $8.76 Cyclogyl
(Alcon)
1 July 2014 1 October 2014
Dapsone Tab 100 mg;
100 tablets
$110.00 $110.00 Dapsone
(Link)
1 July 2014 1 October 2014
Dapsone Tab 25 mg;
100 tablets
$95.00 $95.00 Dapsone
 (Link)
1 July 2014 1 October 2014
Dexamethasone with neomycin sulphate and polymyxin B sulphate Eye drops 0.1% with neomycin sulphate 0.35% and polymyxin B sulphate 6,000 u per ml ;
5 ml OP, dropper bottle
$4.50 $4.50 Maxitrol
(Alcon)
1 July 2014 1 October 2014
Dexamethasone with neomycin sulphate and polymyxin B sulphate Eye oint 0.1% with neomycin sulphate 0.35% and polymyxin B sulphate 6,000 u per g;
3.5 g OP tube
$5.39 $5.39 Maxitrol
(Alcon)
1 July 2014 1 October 2014
Diclofenac sodium Eye drops 0.1%;
5 ml OP, dropper bottle
$13.80 $13.80 Voltaren Ophtha Eye Drop 5mL
(Alcon)
1 July 2014 1 October 2014
Isosorbide mononitrate Tab 20 mg;
100 tablets blister pack
$17.10 $17.10 Ismo 20
(Riemser)
1 July 2014 1 October 2014
Lithium carbonate Cap 250 mg;
 100 capsules bottle pack
$9.42 $9.42 Douglas
(Douglas)
1 July 2014 1 October 2014
Lodoxamide Eye drops 0.1%;
10 ml OP, dropper bottle
$8.71 $8.71 Lomide
(Alcon)
1 July 2014 1 October 2014
Mebeverine hydrochloride Tab 135 mg ;
90 tablets blister pack
$18.00 $18.00 Colofac
(Abbott)
1 July 2014 1 October 2014
Naphazoline hydrochloride Eye drops 0.1%;
15 ml OP, dropper bottle
$4.15 $4.15 Naphcon Forte 
(Alcon)
1 July 2014 1 October 2014
Paraffin liquid with wool fat  Eye oint 3% with wool fat 3%;
3.5 g OP, tube
$3.63 $3.63 Poly-Visc
 (Alcon)
1 May 2014 1 August 2014
Pilocarpine hydrochloride Eye drops 1%;
15 ml OP, dropper bottle
$4.26 $4.26 Isopto
 (Alcon)
1 July 2014 1 October 2014
Pilocarpine hydrochloride Eye drops 2%;
15 ml OP, dropper bottle
$5.35 $5.35 Isopto
 (Alcon)
1 July 2014 1 October 2014
Pilocarpine hydrochloride Eye drops 4%;
15 ml OP, dropper bottle
$7.99 $7.99 Isopto
 (Alcon)
1 July 2014 1 October 2014
Poloxamer Oral drops 10%;
30 ml OP, bottle
$3.78 $3.78 Coloxyl
(Aspen)
1 July 2014 1 October 2014
Procaine penicillin  Inj 1.5 g in 3.4 ml syringe;
 5 syringes
$123.50 $123.50 Cilicaine
(Aspen)
1 July 2014 1 October 2014
Temazepam Tab 10 mg ;
25 tablets, blister pack
$1.27 $1.27 Normison
(Aspen)
1 July 2014 1 October 2014
Testosterone cypionate   Inj 100 mg per ml, 10 ml vial;
1 vial
$76.50 $76.50 Depo-Testosterone (Pfizer) 1 July 2014 1 October 2014
Tobramycin   Eye drops 0.3%;
5 ml OP, dropper bottle
$11.48 $11.48 Tobrex
(Alcon)
1 July 2014 1 October 2014
Tobramycin Eye oint 0.3%;
3.5 g OP, tube
$10.45 $10.45 Tobrex
 (Alcon)
1 July 2014 1 October 2014
Verapamil hydrochloride Tab 80 mg;
 100 tablets, blister pack
$11.74 $11.74 Isoptin
(Abbott)
1 July 2014 1 October 2014

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

Tenders awarded to pharmaceuticals where no brand is listed.

The decisions were as follows:

Chemical Name Presentation; Pack size and type Pack price Hospital Supply Brand (Supplier) DV Limit Listing date Hospital Supply Status date
Betaxolol Eye drops 0.25%;
5 ml , dropper bottle
$11.80 Betoptic S
(Alcon)
1% 1 July 2014 1 September 2014
Betaxolol Eye drops 0.5%;
5 ml , dropper bottle
$7.50 Betoptic
(Alcon)
1% 1 July 2014 1 September 2014
Cyclopentolate hydrochloride Eye drops 1%;
15 ml , dropper bottle
$8.76 Cyclogyl
(Alcon)
1% 1 July 2014 1 September 2014
Lodoxamide Eye drops 0.1%;
10 ml , dropper bottle
$8.71 Lomide
(Alcon)
1% 1 July 2014 1 September 2014
Pilocarpine hydrochloride Eye drops 1%;
15 ml , dropper bottle
$4.26 Isopto
 (Alcon)
1% 1 July 2014 1 September 2014
Pilocarpine hydrochloride Eye drops 2%;
15 ml , dropper bottle
$5.35 Isopto
 (Alcon)
1% 1 July 2014 1 September 2014
Pilocarpine hydrochloride Eye drops 4%;
15 ml , dropper bottle
$7.99 Isopto
 (Alcon)
1% 1 July 2014 1 September 2014

Tenders awarded to listed pharmaceuticals where only the current brand is listed.

The decisions were as follows:

Chemical Name Presentation; Pack size and type Current pack price New pack price Hospital Supply Brand (Supplier) DV Limit Date of price change Hospital Supply Status date
Acetazolamide Tab 250 mg;
100 tablets, bottle
$17.03 $17.03 Diamox
(Aspen)
1% 1 July 2014 1 October 2014 
1 September 2014
Atropine sulphate Eye drops 1%;
15 ml, dropper bottle
$17.36 $17.36 Atropt
(Aspen)
1% 1 May 2014 1 July 2014
Bupivacaine hydrochloride Inj 2.5 mg per ml, 100 ml bag; 5 bags $150.00 $150.00 Marcain (AstraZeneca) 1% 1 May 2014 1 July 2014
Bupivacaine hydrochloride  Inj 5 mg per ml, 4 ml ampoule; 5 ampoules $50.00 $50.00 Marcain Isobaric (AstraZeneca) 1% 1 May 2014 1 July 2014
Bupivacaine hydrochloride with adrenaline Inj 2.5 mg per ml with adrenaline 1:400,000, 20 ml vial ;
Single dose Top Hat SDV 20 ml vials, 5 dose units
$135.00 $135.00 Marcain with Adrenaline
(AstraZeneca)
1% 1 July 2014 1 September 2014
Bupivacaine hydrochloride with adrenaline - Inj 5 mg per ml with adrenaline 1:200,000, 20 ml vial;
single dose top hat 20 ml vial, 5 dose units
$115.00 $115.00 Marcain with Adrenaline
(AstraZeneca)
1% 1 July 2014 1 September 2014
Dapsone Tab 100 mg; 100 tablets $110.00 $110.00 Dapsone
(Link)
1% 1 July 2014 1 September 2014
Dapsone Tab 25 mg ; 100 tablets $95.00 $95.00 Dapsone
 (Link)
1% 1 July 2014 1 September 2014
Dexamethasone with neomycin sulphate and polymyxin B sulphate Eye drops 0.1% with neomycin sulphate 0.35% and polymyxin B sulphate 6,000 u per ml ;
5 ml , dropper bottle
$4.50 $4.50 Maxitrol
(Alcon)
1% 1 July 2014 1 September 2014
Dexamethasone with neomycin sulphate and polymyxin B sulphate Eye oint 0.1% with neomycin sulphate 0.35% and polymyxin B sulphate 6,000 u per g; 3.5 g , tube $5.39 $5.39 Maxitrol
(Alcon)
1% 1 July 2014 1 September 2014
Diclofenac sodium Eye drops 0.1%;
5 ml , dropper bottle
$13.80 $13.80 Voltaren Ophtha Eye Drop 5mL (Alcon) 1% 1 July 2014 1 September 2014
Isosorbide mononitrate Tab 20 mg;
100 tablets blister pack
$17.10 $17.10 Ismo-20
(Riemser)
1% 1 July 2014 1 September 2014
Lithium carbonate Cap 250 mg;
100 capsules bottle pack
$9.42 $9.42 Douglas
 (Douglas)
1% 1 July 2014 1 September 2014
Lodoxamide

Eye drops 0.1%;
10 ml , dropper bottle

$8.71 $8.71

Lomide
(Alcon)

1% 1 July 2014 1 September 2014
Mebeverine hydrochloride Tab 135 mg ;
90 tablets blister pack
$18.00 $18.00 Colofac
(Abbott)
1% 1 July 2014 1 September 2014
Naphazoline hydrochloride Eye drops 0.1%;
15 ml dropper bottle
$4.15 $4.15 Naphcon Forte 
(Alcon)
1% 1 July 2014 1 September 2014
Paraffin liquid with wool fat  Eye oint 3% with wool fat 3% 3.5 g , tube $3.63 $3.63 Poly-Visc
 (Alcon)
1% 1 May 2014 1 July 2014
Poloxamer Oral drops 10%;
30 ml , bottle
$3.78 $3.78 Coloxyl
(Aspen)
1% 1 July 2014 1 September 2014
Procaine penicillin  Inj 1.5 g in 3.4 ml syringe;
 5 syringes
$123.50 $123.50 Cilicaine
(Aspen)
1% 1 July 2014 1 September 2014
Temazepam Tab 10 mg ;
25 tablets, blister pack
$1.27 $1.27 Normison
(Aspen)
1% 1 July 2014 1 September 2014
Testosterone cypionate  Inj 100 mg per ml, 10 ml vial; 1 vial $76.50 $76.50 Depo-Testosterone (Pfizer) 1% 1 July 2014 1 September 2014
Tobramycin  Eye drops 0.3%;
5 ml , dropper bottle
$11.48 $11.48 Tobrex
(Alcon)
1% 1 July 2014 1 September 2014
Tobramycin Eye oint 0.3%;
3.5 g , tube
$10.45 $10.45 Tobrex
(Alcon)
1% 1 July 2014 1 September 2014
Verapamil hydrochloride Tab 80 mg;
 100 tablets, blister pack
$11.74 $11.74 Isoptin
(Abbott)
1% 1 July 2014 1 September 2014

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status

PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2012/13 Invitation to Tender, dated 31 October 2012 and the 2013/14 Invitation to Tender, dated 07 November 2013:

2012/13 Invitation to tender

Chemical Name Line Item
Pramipexole hydrochloride Tab 0.5 mg

2013/14 Invitation to Tender

Chemical Name Line Item Chemical Name Line Item
Acetazolamide     Inj 500mg Cyclopentolate hydrochloride Eye drops 1%, single dose
Aprepitant Cap 125 mg Doxycycline hydrochloride Tab 50 mg
Aprepitant Cap 40 mg Metoclopramide hydrochloride Oral liq 5 mg per 5 ml
Aprepitant Cap 80 mg Pilocarpine hydrochloride Eye drops 2% single dose
Atropine sulphate Eye drops 1%, single dose Timolol maleate Tab 10 mg
Cyclopentolate hydrochloride Eye drops 0.5%, single dose Verapamil hydrochloride Tab 40 mg

For products included in the 2011/12 Invitation to Tender, 2012/13 or the 2013/14 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or Chief Executive) approval. We will keep you informed of any updates regarding such tender products as decisions are made. 

If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.